The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor
Abstract
Peptide hormones such as ANG II and endothelin contribute to cardiac remodeling after myocardial infarction by stimulating myocyte hypertrophy and myofibroblast proliferation. In contrast, angiotensin-(1–7) [ANG-(1–7)] infusion after myocardial infarction reduced myocyte size and attenuated ventricular dysfunction and remodeling. We measured the effect of ANG-(1–7) on protein and DNA synthesis in cultured neonatal rat myocytes to assess the role of the heptapeptide in cell growth. ANG-(1–7) significantly attenuated either fetal bovine serum- or endothelin-1-stimulated [3 H]leucine incorporation into myocytes with no effect on [3 H]thymidine incorporation. [d-Ala 7]-ANG-(1–7), the selective ANG type 1–7 (AT 1–7) receptor antagonist, blocked the ANG-(1–7)-mediated reduction in protein synthesis in cardiac myocytes, whereas the AT 1 and AT 2 angiotensin peptide receptors were ineffective. Serum-stimulated ERK1/ERK2 mitogen-activated protein kinase activity was significantly decreased by ANG-(1–7) in myocytes, a response that was also blocked by [d-Ala 7]-ANG-(1–7). Both rat heart and cardiac myocytes express the mRNA for the mas receptor, and a 59-kDa immunoreactive protein was identified in both extracts of rat heart and cultured myocytes by Western blot hybridization with the use of an antibody to mas, an ANG-(1–7) receptor. Transfection of cultured myocytes with an antisense oligonucleotide to the mas receptor blocked the ANG-(1–7)-mediated inhibition of serum-stimulated MAPK activation, whereas a sense oligonucleotide was ineffective. These results suggest that ANG-(1–7) reduces the growth of cardiomyocytes through activation of the mas receptor. Because ANG-(1–7) is elevated after treatment with angiotensin-converting enzyme inhibitors or AT 1 receptor blockers, ANG-(1–7) may contribute to their beneficial effects on cardiac dysfunction and ventricular remodeling after myocardial infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Sadoshima, J., & Izumo, S. (1993) · Circulation Research · doi:10.1161/01.res.73.3.413 · Cited by 1,427
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
Bueno, O. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6341 · Cited by 774
Ishiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B., & Ferrario, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000124667.34652.1a · Cited by 564
Self-citationCounterregulatory Actions of Angiotensin-(1-7)
Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B., & Diz, D. I. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.535 · Cited by 509
Self-citationAngiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide
Brosnihan, K. B., Li, P., & Ferrario, C. M. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.523 · Cited by 404
Self-citationInvolvement of Extracellular Signal-Regulated Kinases 1/2 in Cardiac Hypertrophy and Cell Death
Bueno, O. F., & Molkentin, J. D. (2002) · Circulation Research · doi:10.1161/01.res.0000038488.38975.1a · Cited by 397
Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats
Loot, A. E., Roks, A. J. M., Henning, R. H., Tio, R. A., Suurmeijer, A. J. H., Boomsma, F., & van Gilst, W. H. (2002) · Circulation · doi:10.1161/01.cir.0000013847.07035.b9 · Cited by 321
Jones, D. W., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000110061.06674.ca · Cited by 309
Zisman, L. S., Keller, R. S., Weaver, B., Lin, Q., Speth, R., Bristow, M. R., & Canver, C. C. (2003) · Circulation · doi:10.1161/01.cir.0000094734.67990.99 · Cited by 308
Krieger, E. M., Brum, P. C., & Negrão, C. E. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.720 · Cited by 306
Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth
Freeman, E. J., Chisolm, G. M., Ferrario, C. M., & Tallant, E. A. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.104 · Cited by 295
Self-citationSantos, R. A. S., Campagnole-Santos, M. J., Baracho, N. C. V., Fontes, M. A. P., Silva, L. C. S., Neves, L. A. A., R. Oliveira, D., Caligiorne, S. M., Rodrigues, A. R. V., Gropen, C., et al. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90104-x · Cited by 286
Pörsti, I., Bara, A. T., Busse, R., & Hecker, M. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14787.x · Cited by 239
Luque, M., Martin, P., Martell, N., Fernandez, C., Brosnihan, K. B., & Ferrario, C. M. (1996) · Journal of Hypertension · doi:10.1097/00004872-199606000-00017 · Cited by 230
Self-citationVascular gp91 phox : Beyond the Endothelium
Pagano, P. J. (2000) · Circulation Research · doi:10.1161/01.res.87.1.1 · Cited by 229
Iyer, S. N., Ferrario, C. M., & Chappell, M. C. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.356 · Cited by 228
Self-citationIyer, S. N., Chappell, M. C., Averill, D. B., Diz, D. I., & Ferrario, C. M. (1998) · Hypertension · doi:10.1161/01.hyp.31.2.699 · Cited by 227
Self-citationAntihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats
Benter, I. F., Ferrario, C. M., Morris, M., & Diz, D. I. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.1.h313 · Cited by 225
Self-citationGlennon, P. E., Kaddoura, S., Sale, E. M., Sale, G. J., Fuller, S. J., & Sugden, P. H. (1996) · Circulation Research · doi:10.1161/01.res.78.6.954 · Cited by 206
Angiotensin II Stimulation of Left Ventricular Hypertrophy in Adult Rat Heart
Baker, K. M., & Dostal, D. E. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.5.276 · Cited by 203
Cardiovascular actions of angiotensin(1–7)
Benter, I. F., Diz, D. I., & Ferrario, C. M. (1993) · Peptides · doi:10.1016/0196-9781(93)90097-z · Cited by 201
Self-citationAngiotensin-(1–7) Reduces Smooth Muscle Growth After Vascular Injury
Strawn, W. B., Ferrario, C. M., & Tallant, E. A. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.207 · Cited by 184
Self-citationNephrectomy, converting enzyme inhibition, and angiotensin peptides.
Campbell, D. J., Kladis, A., & Duncan, A. M. (1993) · Hypertension · doi:10.1161/01.hyp.22.4.513 · Cited by 180
Renal actions of angiotensin-(1-7): in vivo and in vitro studies
Handa, R. K., Ferrario, C. M., & Strandhoy, J. W. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.1.f141 · Cited by 169
Self-citationMolecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7)
Tallant, E. A., & Clark, M. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000090322.55782.30 · Cited by 167
Self-citationRockman, H. A., Wachhorst, S. P., Mao, L., & Ross, J. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.6.h2468 · Cited by 160
Natriuretic action of angiotensin(1–7)
DelliPizzi, A., Hilchey, S. D., & Quilley, C. P. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14014.x · Cited by 154
Fontes, M. A. P., Silva, L. C. S., Campagnole‐Santos, M. J., Khosla, M. C., Guertzenstein, P. G., & Santos, R. A. S. (1994) · Brain Research · doi:10.1016/0006-8993(94)91171-1 · Cited by 150
Signalling pathways in cardiac myocyte hypertrophy.
Sugden, P. H. (2001) · PubMed · Cited by 148
Differential responses to angiotensin-(1–7) in the feline mesenteric and hindquarters vascular beds
Osei, S. Y., Ahima, R. S., Minkes, R. K., Weaver, J. P., Khosla, M. C., & Kadowitz, P. J. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90703-k · Cited by 147
Antiproliferative Actions of Angiotensin-(1-7) in Vascular Smooth Muscle
Tallant, E. A., Diz, D. I., & Ferrario, C. M. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.950 · Cited by 133
Self-citationCardiac Angiotensin-(1-7) in Ischemic Cardiomyopathy
Averill, D. B., Ishiyama, Y., Chappell, M. C., & Ferrario, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000092888.63239.54 · Cited by 132
Self-citationUeyama, T., Kawashima, S., Sakoda, T., Rikitake, Y., Ishida, T., Kawai, M., Yamashita, T., Ishido, S., Hotta, H., & Yokoyama, M. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1135 · Cited by 125
Angiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule.
Garcia, N. H., & Garvin, J. L. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v541133 · Cited by 115
Angiotensin-(1-7) Formation in the Intact Human Heart
Zisman, L. S., Meixell, G. E., Bristow, M. R., et al. (2003) · Circulation · doi:10.1161/01.cir.0000094733.61689.d4 · Cited by 114
Aoki, H., Richmond, M. J., Izumo, S., & Sadoshima, J. (2000) · Biochemical Journal · doi:10.1042/bj3470275 · Cited by 109
Angiotensin-(1-7) and Nitric Oxide Interaction in Renovascular Hypertension
Nakamoto, H., Ferrario, C. M., Fuller, S. B., Robaczewski, D. L., Winicov, E., & Dean, R. H. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.796 · Cited by 109
Self-citationAngiotensin-(1-7). A member of circulating angiotensin peptides.
Kohara, K., Brosnihan, K. B., Chappell, M. C., Khosla, M. C., & Ferrario, C. M. (1991) · Hypertension · doi:10.1161/01.hyp.17.2.131 · Cited by 108
Self-citationRole of Angiotensin-(1-7) in the Modulation of the Baroreflex in Renovascular Hypertensive Rats
Britto, R. R., Santos, R. A. S., Fagundes-Moura, C. R., Khosla, M. C., & Campagnole‐Santos, M. J. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.549 · Cited by 94
Jaiswal, N., Tallant, E. A., Jaiswal, R. K., Diz, D. I., & Ferrario, C. M. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38196-6 · Cited by 74
Self-citationFuller, S. J., DAVIES, E. L., GILLESPIE-BROWN, J., Sun, H., & Tonks, N. K. (1997) · Biochemical Journal · doi:10.1042/bj3230313 · Cited by 63
The renin-angiotensin system during acute myocardial ischemia in dogs.
Santos, R. A. S., Brum, J. M., Brosnihan, K. B., & Ferrario, C. M. (1990) · Hypertension · doi:10.1161/01.hyp.15.2_suppl.i121 · Cited by 62
Self-citationTallant, E. A., & Ferrario, C. M. (1996) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.5.9.1201 · Cited by 14
Self-citation
Cited by
Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J.-C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020) · Circulation Research · doi:10.1161/circresaha.120.317015 · Cited by 1,882
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Renin-angiotensin system and cardiovascular risk
Schmieder, R. E., Hilgers, K. F., Schlaich, M. P., & Schmidt, B. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60242-6 · Cited by 663
ACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis
Simões e Silva, A., Silveira, K., Ferreira, A., & Teixeira, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12159 · Cited by 542
Metadata
- Authors
- Tallant, E. A., Ferrario, C. M., & Gallagher, P. E.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2005-10
- Volume
- 289
- Issue
- 4
- Pages
- H1560-H1566
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2151190145
- Cited by
- 318
- References
- 46
- FWCI
- 14.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.